Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase (Q42588518)

From Wikidata
Jump to navigation Jump to search
scientific article published on 28 December 2010
edit
Language Label Description Also known as
English
Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase
scientific article published on 28 December 2010

    Statements

    Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase (English)
    1 reference
    0 references
    0 references
    Li Zhou
    1 reference
    Yiting Yu
    1 reference
    Chun Ng
    1 reference
    Yongkai Mo
    1 reference
    Wa Shen
    1 reference
    Guanghui Kong
    1 reference
    Ellen Friedman
    1 reference
    Lei Yan
    1 reference
    Jonathan M Yingling
    1 reference
    Michael M Lahn
    1 reference
    Amit Verma
    1 reference
    28 December 2010
    1 reference
    71
    1 reference
    955-963
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit